Up a level |
Chan, Yi-Hsin, Chao, Tze-Fan, Chen, Shao-Wei, Lee, Hsin-Fu, Chen, Wei-Min, Li, Pei-Ru ORCID: 0000-0001-7744-0555, Yeh, Yung-Hsin, Kuo, Chi-Tai, See, Lai-Chu and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2022)
Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan.
JAMA network open, 5 (11).
e2243307-.
Chan, Yi-Hsin, Chao, Tze-Fan, Lee, Hsin-Fu, Yeh, Yung-Hsin, Chang, Shang-Hung, Kuo, Chi-Tai, Lip, Gregory YH ORCID: 0000-0002-7566-1626 and Chen, Shih-Ann
(2022)
Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation.
JACC. Asia, 2 (1).
pp. 46-58.
Chan, Yi-Hsin, Wu, Lung-Sheng, See, Lai-Chu, Liu, Jia-Rou, Chang, Shang-Hung, Chao, Tze-Fan, Yeh, Yung-Hsin, Kuo, Chi-Tai, Lee, Hsin-Fu and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2020)
Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 105 (9).
pp. 2893-2904.
Chan, Yi-Hsin, Lee, Hsin-Fu, Li, Pei-Ru, Liu, Jia-Rou, Chao, Tze-Fan, Wu, Lung-Sheng, Tung, Ying-Chang, Yeh, Yung-Hsiang, Kuo, Chi-Tai, See, Lai-Chu et al (show 1 more authors)
(2020)
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants.
CARDIOVASCULAR DIABETOLOGY, 19 (1).
63-.
Chan, Yi-Hsin, Chao, Tze-Fan, Chen, Shao-Wei, Lee, Hsin-Fu, Yeh, Yung-Hsin, Huang, Ya-Chi, Chang, Shang-Hung, Kuo, Chi-Tai, Lip, Gregory YH ORCID: 0000-0002-7566-1626 and Chen, Shih-Ann
(2020)
Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.
HEART RHYTHM, 17 (12).
pp. 2102-2110.
Chao, Tze-Fan, Chan, Yi-Hsin, Tsai, Pei-Chien, Lee, Hsin-Fu, Chang, Shang-Hung, Kuo, Chi-Tai, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Chen, Shih-Ann and Yeh, Yung-Hsin ORCID: 0000-0003-1645-1941
(2022)
Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban.
Biomedicines, 10 (12).
3210-.
Chan, Yi-Hsin, Chao, Tze-Fan, Chen, Shao-Wei, Lee, Hsin-Fu, Li, Pei-Ru, Chen, Wei-Min, Yeh, Yung-Hsin, Kuo, Chi-Tai, See, Lai-Chu and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2022)
The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.
Cardiovascular diabetology, 21 (1).
118-.